Reumatología Clínica (English Edition)
Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
Alberto Jiménez-Morales; Rafael Cáliz; Susana Aceituno; Miriam Prades; Carles Blanch;
Reumatol Clin. 2021;17:536-42
Adalimumab treatment of resistant chondrocalcinosis
Fatih Tastekin; Kenan Aksu;
Reumatol Clin. 2024;20:452-3
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41